Experience the new nddHub
ndd Medical Technologies

Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosisâa real world study

2023 Frontiers in Pharmacology https://doi.org/10.3389/fphar.2023.1125853

Authors

Dorothea Appelt, Gratiana Steinkamp, Sarah Sieber, Helmut Ellemunter

Study site (country)

Indications

ndd products mentioned in this publication

EasyOne Pro

EasyOne Pro

Portable DLCO, Lung Volumes and Spirometry


Other publications by indication

Take the next step
Don't miss what's next!

Exclusive offers, updates, and more.

Sign up today!